Buscar resultados de ensayos clínicos
Lymphoma, Primary Effusion - 14 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies Condición:
|
Recruiting |
Nombre del estudio: 124I-FIAU Imaging in EBV and KSHV Associated Cancers Condición:
Intervenciones: |
NOT_YET_RECRUITING |
Nombre del estudio: Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma Condición: Fecha: 2024-05-19 Intervenciones: Daratumumab SC (daratumumab and hyaluronidase) is administered subcutaneously (SC) as 1800 mg/30,000 units weekly for a total of 8 weeks (8 doses |